Outstanding executive contributions providing essential insight from:

  • Dr. Amin Al Amiri
    Executive Director for Medical Practices and Licenses
    Ministry of Health
  • Dr. Saleh Bawazier
    Vice President of the Drug Sector
    Saudi Food and Drug Authority Contact (SFDA)
  • Alaa Assem
    Director, Strategic Public Affairs & Policy - Middle East Region
    Pfizer
  • Dr. Omar Shafey
    Senior Officer, Medical Research Public Health & Research Department
    Health Authority Abu Dhabi
  • Dr. Satish Chandra
    Specialist and Head Clinical Research
    Tawam Hospital

Tackling issues in Clinical Trials across the Middle East and North Africa to promote best practice methodology in your research practice

According to Clinicaltrials.gov, between 2006 and 2009, while nearly 7,000 industry-sponsored trials were conducted in Europe but the number conducted in the Middle East was less than 400. However, this is changing. The introduction of big pharmaceuticals into the market place has shifted the focus particularly to the Middle East.

It is estimated that the Middle East will command $15 billion worth of pharmaceutical sales by 2015. As the Arab world adopts western lifestyles the repercussions are more than apparent with World Health Organisation (WHO) reporting the region having the highest rate of diabetes in the world.

With the demand for increased studies in Arab patients together with the lower running costs in brand new facilities in comparison to the rest of the world, the Middle East is certainly on track to exceed future clinical trial figures.

IQPC’s Clinical Trial’s MENA summit will combine leaders from multi-national pharmaceutical companies from the region and around the world as well as government and regulatory figures to discuss issues and proposed solutions that may occur in the regions predicted growth in clinical trial’s.

Key topics of discussion include:

  • Discussing confidentiality of agreements across boarders to significantly improve the transparency and efficiency of clinical research results
  • Highlighting the strengths and weakness in using contract research organisations (CRO’s) in different countries across the MENA regions compared to the west
  • Developing cost efficient clinical trial logistics to ensure stability and integrity throughout the whole clinical trial supply chain – also considering temperature sensitive products in the MENA climate
  • Analysis of clinical tools, technology and systems including forecasting technology to meet demand
  • Understanding regulatory challenges that may be faced in the MENA region and how they align with global standards set by the Food and Drug Administration (FDA)
  • Examining patient recruitment strategy in the region and identifying the diverse patient pool the region has at it’s disposal

Who will you network with at Clinical Trials MENA?

Join leaders from multi-national pharmaceutical and biotech companies, government and regulatory boards with key job titles including:

  • Vice Presidents, Directors, Heads and Scientists:
    • Clinical Research
    • Regulatory Affairs
    • Clinical Supply Operations
    • Clinical Quality Assurance/Quality Control
    • Project Management
    • Clinical Trials Logistics
  • Government and Regulatory Representatives
  • Professors and Doctors:
    • Clinical Trials
    • Clinical Research
    • Drug Development
  • Clinical Research Organisations (CRO's)
  • Clinical Trials Solution Providers
Exhibitor Exhibitor
ExhibitorExhibitor
Media Partners
animatedmediapart

[ Register Now ]